The Legal 500

Chambers of Christopher Rees

20 CATHEDRAL ROAD, CARDIFF, CF11 9LJ, WALES
Tel:
Work 02920 232032
Fax:
Fax 02920 233636
DX:
141874 CARDIFF 28
Email:
Web:
www.apexchambers.net

Nicholas Gedge

Tel:
Work 029 2023 2032
Email:
Apex Chambers (Chambers of Christopher Rees)

Position

Criminal law: defence and prosecution (CPS grade 4 prosecutor and member of Serious Organised Crime Panel and Attorney Generars list). General crime plus regular representation of medical professionals in criminal cases. Significant cases include: defence: Operation Jasmine (counsel for GP in 2 month trial re allegations of dishonesty and making false declarations on a cremation certificate); R v Dr O (junior counsel for GP accused of attempted rape and indecent assault); R v Or P (counsel for GP accused of serial prescription fraud); R v D (counsel for dental hygienist accused of indecently assaulting a patient); R v S (counsel for GP accused of sexually assaulting two patients) ; Operation Corolla junior defence counsel in major Class A drug conspiracy). Prosecution: Operation Washer junior defence counsel in £1m+ car ringing conspiracy); Operation Rebus (prosecution junior in major Class A drug conspiracy); Operation Texas (prosecution junior in over 60kg Manchester/South Wales heroin conspiracy). Professional discipline: representation of medical professionals in disciplinary hearings (General Medical Council, General Dental Council, General Council of Chiropractors, Health Professions Council) and also police officers in disciplinary proceedings. Significant cases include: GMC v Dr B, counsel for hospital doctor in connection with allegations of dishonesty relating to prescriptions and the taking of controlled drugs outside the jurisdiction; GMC v DrS, counsel for consultant – allegations of dishonesty re the misappropriation and misuse of medical research; GMC v Dr R & Dr R, counsel for consultant and GP re allegations of misconduct in the running of a care horne; GOC v A, counsel for dental hygienist-fitness to practice re criminal convictions; Re Sgt M, counsel for custody sergeant in disciplinary proceedings re death in custody. Inquests: regular representation of medical professionals and health trusts in inquests. Significant cases include: ReG, counsel for prison doctor in high profile five-week inquest re death of prisoner In HMP Blakenhurst; Re H, counsel for health trust re death of prisoner in HMP Stafford; ReD, counsel for prison doctor re death of prisoner In HMP Bristol; Re H, counsel for health trust re death of psychiatric patient on escorted home visit.

Career

Called 2000; Middle Temple.

Education

Eton College; Cambridge University, St John’s College (MA).

Leisure

Music, family, sport, horses.

Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • China Drug Registration Regulation - Public consultation on amendment closes - March 2014

    In February 2014, the China Food and Drug Administration (“CFDA”) invited second-round comments from the public regarding proposed amendments to the China Drug Registration Regulations (“DRR”). One of the proposed amendments touches upon patent protection for drugs in China.
  • Revised NDRC Measures for Approval and Filing of Outbound Investment Projects - April 2014

    The National Development and Reform Commission ( NDRC ) released a new set of Management Measures for Approval and Filing of Outbound Investment Projects ( 境外投资项目核准和备案管理办法) ( New Measures ) on 8 April 2014. The New Measures take effect on 8 May 2014 and will replace the Interim Management Measures for Approval of Outbound Investment Projects ( 境外投资项目核准暂行管理办法) ( Original Measures ) which have been in force since 9 October 2004.
  • Insurance Update - CIRC Issues Insurance M&A Measures: What are the impacts and applications?

    On 21 March 2014, CIRC issued the Administrative Measures on the Acquisition and Merger of Insurance Companies (the Insurance M&A Measures ) which will take effect from 1 June 2014. The Insurance M&A Measures apply to M&A activities whereby an insurance company is the target for a merger or acquisition. The target insurance company could be either a domestic or a foreign invested insurer. However, the Insurance M&A Measures will not apply to any equity investment by insurance companies in non-insurance companies in China or in overseas insurance companies.
  • China issues new rules to regulate medical devices - May 2014

    The Regulations on Supervision and Administration of Medical Devices (in Chinese《医疗器械监督管理条例》, State Council Order No. 650) (the Medical Device Regulations) were amended by China's State Council on 31 March 2014 and will come into effect on 1 June 2014. This is the first amendment in more than a decade since the Medical Device Regulations were first promulgated in 2000, even though the amendment was initiated eight years ago in 2006. The 2014 amendment unveils reforms on the regulatory regime for medical devices market in China from various aspects.
  • Walking a fine line in China:Distinguishing between legitimate commercial deals and commercial bribe

    China in the 21st century exemplifies an atmosphere of great opportunity and intense competition. Against this backdrop, it has become increasingly common for businesses to adopt a variety of practices in order to make their products and services competitive. Such practices may include paying middle-men to promote sales and giving incentives to buyers directly. However, whilst revenue spikes are undoubtedly welcome, businesses should bear in mind the potential backlash arising out of these commercial arrangements. The risk that such arrangements may not comply with anti-bribery and corruption laws and therefore cause business significant damage in the long term should not be underestimated.
  • Rise of the private healthcare sector - July 2014

    As of 2013, China had 9,800 private hospitals, representing almost half of the total number of hospitals in the country 1 . However, private hospitals still severely lag behind their public peers due to low utilisation, talent shortages and incomplete social insurance coverage. As part of China's ongoing healthcare reform initiatives, the Chinese government has set a goal to increase the share of patients treated by private hospitals to 20% by the end of 2015 2 .
  • Banking regulation in China: Proposed deposit insurance system - December 2014

    On 30 November 2014, the State Council of China released a draft Deposit Insurance Regulation (the Draft), to establish a deposit insurance system in order to "protect interests of depositors, prevent and mitigate financial risks and maintain a stabilised financial system". The public are invited to submit comments on the Draft by 30 December 2014.
  • Tackling bribery: China toughens criminal law - December 2014

    Following earlier reforms of the PRC's anti-corruption rules (for further information, please see our previous briefings published in January 2013 and March 2011 ), the National People's Congress (NPC) has recently published a proposed amendment to the PRC Criminal Law in draft form for public comments (the Draft). The Draft expands the reach of official bribery offences, gives more autonomy to judges to inflict severe punishments, and generally increases the level and type of punishments that can be imposed on individuals who commit bribery offences. It further demonstrates the government's determination to tackle corruption in China.
  • China banking restrictions relaxed: New rules further open banking sector to foreign investors

    The State Council of China recently released amendments to the Foreign Bank Administrative Regulations of China (the Amendments) with effect from 1 January 2015.
  • Walking a Tightrope in Singapore - July 2014

    The world has no borders and distance is negligible for the technologically savvy criminal. Individuals with illicit funds to launder or terrorist activities to finance can, with the latest technology, transfer high volumes of money around the globe almost instantaneously and seek to conceal the origin or the destination of the funds.